c-Kit not approved

Lenvatinib 10mg is suitable for the treatment of hepatocellular carcinoma, renal cell carcinoma, differentiated cancer, and endometrial cancer.

Sale

Lenvatinib 10mg is suitable for the treatment of hepatocellular carcinoma, renal cell carcinoma, differentiated cancer, and endometrial cancer.

Regular price ¥550.00 CNY

Regular price ~~¥900.00 CNY~~ Sale price ¥550.00 CNY
Unit price per

Sale
Lenvatinib is indicated for the treatment of hepatocellular carcinoma, renal cell carcinoma, differentiated cancer, and endometrial cancer.

Sale

Lenvatinib is indicated for the treatment of hepatocellular carcinoma, renal cell carcinoma, differentiated cancer, and endometrial cancer.

Regular price ¥300.00 CNY

Regular price ~~¥450.00 CNY~~ Sale price ¥300.00 CNY
Unit price per

Sale
Lyvioni (Lenvatinib) 4mg

Sale

Lyvioni (Lenvatinib) 4mg

Regular price ¥250.00 CNY

Regular price ~~¥500.00 CNY~~ Sale price ¥250.00 CNY
Unit price per

Sale
Lyvioni (Lenvatinib) Lyvioni, brand name: Levitra, generic name: Lenvatinib, is a kinase inhibitor suitable for the treatment of tumors such as differentiated thyroid cancer (DTC), renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC).

Lyvioni (Lenvatinib) Lyvioni, brand name: Levitra, generic name: Lenvatinib, is a kinase inhibitor suitable for the treatment of tumors such as differentiated thyroid cancer (DTC), renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC).

Regular price ¥550.00 CNY

Regular price Sale price ¥550.00 CNY
Unit price per
Lenvatinib, LENVIDX, Lenvatinib 4mg*30 capsules

Sale

Lenvatinib, LENVIDX, Lenvatinib 4mg*30 capsules

Regular price ¥400.00 CNY

Regular price ~~¥450.00 CNY~~ Sale price ¥400.00 CNY
Unit price per

Sale
Lenvatinib, LENVIDX, Lenvatinib 10mg*30 capsules

Sale

Lenvatinib, LENVIDX, Lenvatinib 10mg*30 capsules

Regular price ¥630.00 CNY

Regular price ~~¥900.00 CNY~~ Sale price ¥630.00 CNY
Unit price per

Sale
LENMAKS 4 Drug name: LENMAKS 4 Generic name: Lenvatinib mesylate capsules/Lenvatinib mesylate capsules/Lenvatinib

LENMAKS 4 Drug name: LENMAKS 4 Generic name: Lenvatinib mesylate capsules/Lenvatinib mesylate capsules/Lenvatinib

Regular price ¥200.00 CNY

Regular price Sale price ¥200.00 CNY
Unit price per
LENMAKS 10 Drug name: LENMAKS 10 Generic name: Lenvatinib mesylate capsules/Lenvatinib mesylate capsules/Lenvatinib

LENMAKS 10 Drug name: LENMAKS 10 Generic name: Lenvatinib mesylate capsules/Lenvatinib mesylate capsules/Lenvatinib

Regular price ¥400.00 CNY

Regular price Sale price ¥400.00 CNY
Unit price per
Dasatinib 70mg Dasatinib is a kinase inhibitor indicated for the treatment of 1. adults newly diagnosed with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML).

Sale

Dasatinib 70mg Dasatinib is a kinase inhibitor indicated for the treatment of 1. adults newly diagnosed with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML).

Regular price ¥400.00 CNY

Regular price ~~¥880.00 CNY~~ Sale price ¥400.00 CNY
Unit price per

Sale
Dasatinib 50mg Dasatinib is a kinase inhibitor indicated for the treatment of 1. adults newly diagnosed with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML).

Sale

Dasatinib 50mg Dasatinib is a kinase inhibitor indicated for the treatment of 1. adults newly diagnosed with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML).

Regular price ¥320.00 CNY

Regular price ~~¥680.00 CNY~~ Sale price ¥320.00 CNY
Unit price per

Sale
Dasatinib 20mg Dasatinib is a kinase inhibitor indicated for the treatment of 1. adults newly diagnosed with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML).

Sale

Dasatinib 20mg Dasatinib is a kinase inhibitor indicated for the treatment of 1. adults newly diagnosed with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML).

Regular price ¥180.00 CNY

Regular price ~~¥480.00 CNY~~ Sale price ¥180.00 CNY
Unit price per

Sale

Item added to your cart

Collection: c-Kit not approved

Lenvatinib 10mg is suitable for the treatment of hepatocellular carcinoma, renal cell carcinoma, differentiated cancer, and endometrial cancer.

Lenvatinib 10mg is suitable for the treatment of hepatocellular carcinoma, renal cell carcinoma, differentiated cancer, and endometrial cancer.

Lenvatinib is indicated for the treatment of hepatocellular carcinoma, renal cell carcinoma, differentiated cancer, and endometrial cancer.

Lenvatinib is indicated for the treatment of hepatocellular carcinoma, renal cell carcinoma, differentiated cancer, and endometrial cancer.

Lyvioni (Lenvatinib) 4mg

Lyvioni (Lenvatinib) 4mg

Lyvioni (Lenvatinib) Lyvioni, brand name: Levitra, generic name: Lenvatinib, is a kinase inhibitor suitable for the treatment of tumors such as differentiated thyroid cancer (DTC), renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC).

Lyvioni (Lenvatinib) Lyvioni, brand name: Levitra, generic name: Lenvatinib, is a kinase inhibitor suitable for the treatment of tumors such as differentiated thyroid cancer (DTC), renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC).

Lenvatinib, LENVIDX, Lenvatinib 4mg*30 capsules

Lenvatinib, LENVIDX, Lenvatinib 4mg*30 capsules

Lenvatinib, LENVIDX, Lenvatinib 10mg*30 capsules

Lenvatinib, LENVIDX, Lenvatinib 10mg*30 capsules

LENMAKS 4 Drug name: LENMAKS 4 Generic name: Lenvatinib mesylate capsules/Lenvatinib mesylate capsules/Lenvatinib

LENMAKS 4 Drug name: LENMAKS 4 Generic name: Lenvatinib mesylate capsules/Lenvatinib mesylate capsules/Lenvatinib

LENMAKS 10 Drug name: LENMAKS 10 Generic name: Lenvatinib mesylate capsules/Lenvatinib mesylate capsules/Lenvatinib

LENMAKS 10 Drug name: LENMAKS 10 Generic name: Lenvatinib mesylate capsules/Lenvatinib mesylate capsules/Lenvatinib

Dasatinib 70mg Dasatinib is a kinase inhibitor indicated for the treatment of 1. adults newly diagnosed with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML).

Dasatinib 70mg Dasatinib is a kinase inhibitor indicated for the treatment of 1. adults newly diagnosed with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML).

Dasatinib 50mg Dasatinib is a kinase inhibitor indicated for the treatment of 1. adults newly diagnosed with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML).

Dasatinib 50mg Dasatinib is a kinase inhibitor indicated for the treatment of 1. adults newly diagnosed with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML).

Dasatinib 20mg Dasatinib is a kinase inhibitor indicated for the treatment of 1. adults newly diagnosed with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML).

Dasatinib 20mg Dasatinib is a kinase inhibitor indicated for the treatment of 1. adults newly diagnosed with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML).

Country/region

Language

Country/region

Language

Collection: c-Kit not approved

Filter and sort

Filter